Recruiting Stroke Studies in Mobile
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis
The primary goal of the trial is to determine if the experimental arms (rivaroxaban or ticagrelor or both) are superior to the clopidogrel arm for lowering the 1-year rate of ischemic stroke, intracer...
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
The primary objective is to establish the efficacy of intra-arterial (IA) mechanical thrombectomy (MT) with extracranial proximal carotid artery acute stenting versus non-stenting approaches in patien...
About Stroke Clinical Trials in Mobile
A stroke occurs when blood flow to part of the brain is interrupted or reduced, depriving brain tissue of oxygen and nutrients. It is a leading cause of disability and death. Rapid treatment is critical, and prevention focuses on managing risk factors like hypertension and atrial fibrillation.
There are currently 2 stroke clinical trials recruiting participants in Mobile, ALABAMA. These studies are seeking a combined 2,087 participants. Research is being sponsored by University of Florida, Mercy Health Ohio. Clinical trial participation is free and participants receive study-related medical care at no cost.
Stroke Clinical Trials in Mobile — FAQ
Are there stroke clinical trials in Mobile?
Yes, there are 2 stroke clinical trials currently recruiting in Mobile, ALABAMA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Mobile?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Mobile research site will contact you about next steps.
Are clinical trials in Mobile free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Mobile studies also compensate for your time and travel.
What stroke treatments are being tested?
The 2 active trials in Mobile are testing new therapies including novel drugs, biologics, and treatment approaches for stroke.
Data updated March 2, 2026 from ClinicalTrials.gov